Prognostic significance of flow-cytometry in squamous cell bronchogenic cancer. Retrospective study of 61 cases;Valeur pronostique de la cytometrie en flux dans les cancers bronchiques epidermoides. Etude retrospective a propos de 61 cas

Bulletin du Cancer

Volumn 84, Issue 6, 1997, Pages 597-602

  Jeanfaivre, Thierry ^a   Chassevent, Agnès ^b   Geslin, Joël ^b   Larra, Francis ^b   Tuchais, Edmond ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b CENTRE PAUL PAPIN   (France)

Author keywords

Flow cytometry; Prognosis; Squamous cell bronchogenic cancer; Survival

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE S PHASE; DNA CONTENT; DNA SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PLOIDY; PREDICTION; PROGNOSIS; ANEUPLOIDY; CANCER STAGING; CHEMISTRY; GENETICS; LUNG CARCINOMA; LUNG TUMOR; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ANEUPLOIDY; CARCINOMA, BRONCHOGENIC; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030856489     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Capewell S, Sudlow MF. Performance and prognosis in patients with lung cancer. Thorax 1990 ; 45 : 951-6.
2. Mountain CF. A new international staging system for Jung cancer. Chest 1986 ; 89 (suppl.) : 225-33.
3. Soorae AS, Smith RA. Tumor size as prognostic factor after resection of lung carcinoma. Thorax 1977 ; 32 : 19-25.
4. Isobe H, Miyamoto H, Shimuzu T, Haneda H, Hashimoto M, Inove K, et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 1990 ; 65 : 1391-5.
5. Sahin A, Ro J, El-Naggar A, Lee J, Ayala A, Teague K, Hong W. Flow cytometric analysis of the DNA content of non-small cell lung cancer ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung. Cancer 1990 ; 65 : 530-7.
6. Ten Velde G, Schutte B, Vermeulen A, Volovics A, Reynders M, Blijham G. Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer. Eur J Cancer Clin Oncol 1988 ; 24 : 455-60.
7. Van Bodegom P, Baak J, Stroet Van Galen C. The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage I resected squamous cell lung cancer and long-term follow up. Cancer 1989 ; 63 : 143-7.
8. Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry 1985 ; 6 : 348-56.
9. Jeanfaivre T, Chassevent A, Larra F, Tuchais E. Apport de la cytométrie en flux dans l'évaluation du pronostic des cancers bronchiques non à petites cellules. Revue de la littérature. Bull Cancer 1994 ; 81 : 605-9.
10. Raber M, Barlogie B, Farquhar D. Determination of ploidy abnormality and cell cycle distribution in human lung cancer using DNA flow cytometry. Proc Am Ass Cancer Res 1980 ; 21 : 40.
11. Zimmerman PV, Bint MH, Hawson GAT, Parsons PG. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987 ; 2 : 530-3.
12. Volm M, Hahn E, Mattern J, Müller T, Vogt-Moykopf I, Weber E. Five-year follow-up of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 1988 ; 48 : 2923-8.
13. Olszewski W, Darzynkiewicz Z, Claps ML, Melamed MR. Flow cytometry of lung carcinoma. A comparison of DNA stemline and cell cycle distribution with histology. Anal Quant Cytol 1982 ; 4 : 90-4.
14. Coulson PB, Thornthwaite JT, Wooley TW, Sugerbaker EV, Seckinger D. Prognostic indicators including DNA histogram type, receptor content, staging related to human breast cancer patient survival. Cancer Res 1984 ; 44 : 4187-96.
15. Smith L, Barlogie B, Alexanian R. Biclonal and hypodiploid multiple myeloma. Am J Med 1986 ; 80 : 841-3.
16. Salvati F, Teodori L, Gagliardi L, Signora M, Aquilini M, Storniello G. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Chest 1989 ; 96 : 1092-8.
17. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest 1991 ; 100 : 422-8.
18. Pater JL, Loeb M. Nonanatomic prognostic factors in carcinoma of the lung. A multivariate analysis. Cancer 1982 ; 50 : 326-31.
19. Fraire AE, Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity. Prognostic implications. Cancer 1987 ; 60 : 370-5.
20. The World Health Organization histological typing of lung tumors. World Health Organization, Geneva, 1981.
21. Zubrod CG, Schneiderman MA, Frei E, Brindley C, Gold LG, Shnider B, et al. Appraisal of methods for the study of chemotherapy in man, comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960 ; 1 1 : 7-23.
22. Vindelov L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch B Cell Pathol 1977 ; 24 : 227-42.
23. Vindelov L, Christensen J, Nissen N. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 1983 ; 3 : 328-31.
24. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984 ; 5 : 445-6.
25. Baisch H, Gohde W, Linden WA. Analysis of PCP data to determine the fraction of cells in various phase of cell cycle. Radiat Environ Biophys 1975 ; 12 : 31-9.
26. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972 ; 34 : 187-220.